Hospital Barros Luco Trudeau Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2004
NCT00643045
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Hospital Barros Luco Trudeau, Servicio de Neurologia, Santiago, Chile

Active Ingredients

Drugs in Phase 4 Trials (1)

colistin (1 trial)

Drugs in Phase 3 Trials (1)

safinamide (xadago) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bacterial Infections (Phase 4)

Gram-Negative Bacterial Infections (Phase 4)

Parkinson Disease (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2